Italy Suspends AstraZeneca’s COVID Vaccine After Teen’s Brain Hemorrhage Death
The government of Italy has suspended AstraZeneca/Oxford University’s experimental AZD1222 COVID-19 vaccine for people under 60 years of age in that country. The decision, announced on June 11, 2021, follows the recent death of 18-year-old Camilla Canepa, who died of a cerebral due to a blood clot 16 days after receiving the first dose of […]
“Breakthrough Cases” of COVID-19 Emerging Among Fully Vaccinated Americans
The U.S. Centers for Disease Control and Prevention (CDC) recommends getting a COVID-19 vaccine, stating that, “COVID-19 vaccines are effective at protecting you from getting sick. Based on what we know about COVID-19 vaccines, people who have been fully vaccinated can start to do some things that they had stopped doing because of the pandemic.”1 […]
Physical Therapist Dies Two Days After Getting COVID-19 Shot in Indiana
A healthy 28-year-old woman in Indiana died unexpectedly at her home on Jan. 21, 2021 two days after receiving an experimental mRNA (messenger ribonucleic acid) biologic for COVID-19. The deceased, Haley Link Brinkmeyer, PhD worked as a physical therapist at the North River Health Campus senior living community in Evansville.1 2 3 “My 28 year […]
Two Elderly Men Die Hours After Getting COVID-19 Vaccines in Israel
A 75-year-old man suffered a heart attack and died two hours after receiving the first dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 vaccine for COVID-19 at a local health clinic in Israel.1 2 3 The elderly man, who was reported to have cancer and a history of heart attacks, was administered the vaccine at […]
Over 3,000 “Health Impact Events” After COVID-19 mRNA Vaccinations
Between Dec. 11 and 18, 2020, the U.S. Food and Drug Administration (FDA) granted Pfizer/BioNTech and Moderna pharmaceutical companies an Emergency Use Authorization (EUA)1 to distribute COVID-19 vaccines using messenger RNA (mRNA) technology that to date has not been licensed for use in humans.2 3 4 5 Although the Advisory Committee on Immunization Practices (ACIP) […]
Peruvian Man Suffers Guillain-Barré-like Symptoms After Receiving Sinopharm COVID-19 Vaccine
On Dec. 11, 2020, Peru’s National Institute of Health (INS) said it was temporarily suspending the Phase 1 clinical trial of an experimental COVID-19 vaccine developed by Sinopharm Group Co. Ltd. of Shanghai, China after one of the participants in the trial who got the vaccine showed difficulty in moving his arms and legs—symptoms of […]